Cargando…

Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy

Knowing the mechanisms that govern the persistence of infected CD4(+) subpopulations could help us to design new therapies to cure HIV-1 infection. We evaluated the simultaneous distribution of the HIV-1 reservoir in 13 CD4(+) subpopulations from 14 HIV-1-infected individuals on antiretroviral thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gálvez, Cristina, Grau-Expósito, Judith, Urrea, Victor, Clotet, Bonaventura, Falcó, Vicenç, Buzón, Maria José, Martinez-Picado, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630536/ https://www.ncbi.nlm.nih.gov/pubmed/34844430 http://dx.doi.org/10.1128/mBio.03078-21

Ejemplares similares

Identification of HIV-reservoir cells with reduced susceptibility to antibody-dependent immune response
por: Astorga-Gamaza, Antonio, et al.
Publicado: (2022)

Latency reversal agents affect differently the latent reservoir present in distinct CD4(+) T subpopulations
por: Grau-Expósito, Judith, et al.
Publicado: (2019)

Extremely low viral reservoir in treated chronically HIV-1-infected individuals
por: Gálvez, Cristina, et al.
Publicado: (2020)

Altered T‐cell subset distribution in the viral reservoir in HIV‐1‐infected individuals with extremely low proviral DNA (LoViReTs)
por: Gálvez, Cristina, et al.
Publicado: (2022)

Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab
por: Serra-Peinado, Carla, et al.
Publicado: (2019)

VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies
por: Puertas, Maria C., et al.
Publicado: (2021)

Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy
por: Bernal, Silvia, et al.
Publicado: (2023)

Erratum for Puertas et al., “VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies”
por: Puertas, Maria C., et al.
Publicado: (2021)

Antiretroviral therapy suppressed participants with low CD4(+) T-cell counts segregate according to opposite immunological phenotypes
por: Pérez-Santiago, Josué, et al.
Publicado: (2016)

KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir
por: Astorga-Gamaza, Antonio, et al.
Publicado: (2023)

Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART
por: Puertas, Maria C., et al.
Publicado: (2016)

Resident memory T cells are a cellular reservoir for HIV in the cervical mucosa
por: Cantero-Pérez, Jon, et al.
Publicado: (2019)

A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4(+) T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients
por: Grau-Expósito, Judith, et al.
Publicado: (2017)

The Genome-wide Methylation Profile of CD4(+) T Cells From Individuals With Human Immunodeficiency Virus (HIV) Identifies Distinct Patterns Associated With Disease Progression
por: Moron-Lopez, Sara, et al.
Publicado: (2020)

Enhancement of Antiviral CD8(+) T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab
por: Blanch-Lombarte, Oscar, et al.
Publicado: (2019)

Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells
por: Grau-Expósito, Judith, et al.
Publicado: (2022)

Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4(+) T-cell immune recovery
por: Gómez-Mora, Elisabet, et al.
Publicado: (2017)

CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir
por: Badia, Roger, et al.
Publicado: (2018)

Switching From a Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy–suppressed Human Immunodeficiency Virus–infected Individuals
por: Morón-López, Sara, et al.
Publicado: (2019)

HIV transfer between CD4 T cells does not require LFA-1 binding to ICAM-1 and is governed by the interaction of HIV envelope glycoprotein with CD4
por: Puigdomènech, Isabel, et al.
Publicado: (2008)

Peripheral and lung resident memory T cell responses against SARS-CoV-2
por: Grau-Expósito, Judith, et al.
Publicado: (2021)

P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gp(high) cells and correlates with HIV-1 viral load
por: Minuesa, Gerard, et al.
Publicado: (2016)

Deep Molecular Characterization of HIV-1 Dynamics under Suppressive HAART
por: Buzón, Maria J., et al.
Publicado: (2011)

Establishment and Replenishment of the Viral Reservoir in Perinatally HIV-1-infected Children Initiating Very Early Antiretroviral Therapy
por: Martínez-Bonet, Marta, et al.
Publicado: (2015)

Viral and Cellular Factors Leading to the Loss of CD4 Homeostasis in HIV-1 Viremic Nonprogressors
por: Colomer-Lluch, Marta, et al.
Publicado: (2022)

Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells
por: Ruiz, Alba, et al.
Publicado: (2019)

The infectious synapse formed between mature dendritic cells and CD4(+) T cells is independent of the presence of the HIV-1 envelope glycoprotein
por: Rodriguez-Plata, Maria T, et al.
Publicado: (2013)

Remodeling the bladder tumor immune microenvironment by mycobacterial species with changes in their cell envelope composition
por: Senserrich, Jordi, et al.
Publicado: (2022)

Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4(+) T-cell immune recovery
por: Gómez-Mora, Elisabet, et al.
Publicado: (2017)

Sensitive quantification of the HIV-1 reservoir in gut-associated lymphoid tissue
por: Morón-López, Sara, et al.
Publicado: (2017)

Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain
por: Llibre, Josep M, et al.
Publicado: (2013)

Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination
por: Duran-Castells, Clara, et al.
Publicado: (2023)

In–Depth Characterization of Viral Isolates from Plasma and Cells Compared with Plasma Circulating Quasispecies in Early HIV-1 Infection
por: Dalmau, Judith, et al.
Publicado: (2012)

Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs
por: Malatinkova, Eva, et al.
Publicado: (2015)

Persistent HIV-1 replication during antiretroviral therapy
por: Martinez-Picado, Javier, et al.
Publicado: (2016)

Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
por: Borgognone, Alessandra, et al.
Publicado: (2022)

Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses
por: Salgado, Maria, et al.
Publicado: (2018)

Hidden costs of antiretroviral treatment: the public health efficiency of drug packaging
por: Andreu-Crespo, Àngels, et al.
Publicado: (2015)

Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs
por: Puertas, Maria C, et al.
Publicado: (2018)

Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence
por: Martinez-Picado, Javier, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aj1bdn7k34837ni6ogc7o7uv2s